RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
89 hedge funds and large institutions have $317M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 80 → 89 (+9)
Holders
89
Holding in Top 10
2
Calls
$258K
Puts
–
Top Buyers
| 1 | +$14.7M | |
| 2 | +$8.71M | |
| 3 | +$5.66M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.24M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$6.22M | |
| 3 | -$5.34M | |
| 4 |
AIC
AWM Investment Company
New York
|
-$3.16M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.59M |